Speaker Profile
M.D., Chief, Division of Neuroimmunology and Glial Biology, UCSF
Biography
Dr. Ari J. Green is Chief of the Division of Neuroimmunology and Glial Biology in the Department of Neurology at the University of California, San Francisco, where he leads more than 20 laboratories and groups dedicated to understanding and treating multiple sclerosis (MS) and related disorders. He also serves as Medical Director of the UCSF MS and Neuroinflammation Center, one of the largest clinics of its kind in the United States. Dr. Green’s research focuses on developing and validating biomarkers to measure remyelination, repair, and disease progression, with the goal of accelerating clinical trials for reparative therapies. His scientific contributions include leading the first successful Phase II clinical trial of a remyelinating agent for MS and developing methods to monitor myelin repair. He also co-directs the Program in Remyelination and Repair with Dr. Jonah Chan and the Neurodiagnostics Center in the Department of Neurology.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Catriona Jamieson, UCSD
Opening talk
• Catriona Jamieson, UCSD
PMWC Award Ceremony
• Judy Faulkner, Epic
• Alexis C. Komor, UCSD
What’s Next at Epic?
• Judy Faulkner, Epic
• Peter DeVault, Epic
RNA Therapeutics Beyond mRNA: siRNA, ASOs, and snRNA
• Chair: Alexis C. Komor, UCSD
• Niren Murthy, UC Berkeley
• Gene Yeo, UCSD
• Reuben Harris, UT Health San Antonio
Stem Cell-Targeted Therapeutics: Small Molecules & Biologics
• Chair: Catriona Jamieson, UCSD
• Irving L. Weissman, Stanford
Space-Omics & Stem-Cell Adaptation
• Chair: Catriona Jamieson, UCSD
• Alysson Muotri, UCSD
In Vivo Gene Therapies
• Chair: Gene Yeo, UCSD
• Mark A Kay, Stanford
• David Schaffer, UC Berkeley
Diagnostics, Prognostics, and Patient Stratification
• Chair: Ezra Cohen, Tempus
• Gudrun Stengel, Alida Biosciences
• Jarret Glasscock, Cofactor Genomics
• "Phil Febbo, Veracyte
Bioprinting Transplantable Liver: mRNA-Driven Multi-Lineage Differentiation from Autologous iPSCs
• Jiwu Wang, The Scintillon Institute
A New Era in Heart Failure Treatment: Delivering on the Promise of iPSC-Derived Cardiomyocyte Therapy
• Eugene Wang, Help Therapeutics
Closing Talk
• Catriona Jamieson, UCSD
